Stenotrophomonas maltophilia infections of intact skin: a systematic review of the literature

Diagnostic Microbiology and Infectious Disease

Volumn 63, Issue 3, 2009, Pages 330-333

  Bin Abdulhak, Aref A ^a   Zimmerman, Valerie ^a   Al Beirouti, Bassim T ^a   Baddour, Larry M ^b   Tleyjeh, Imad M ^a,b  

^a KING FAHAD MEDICAL CITY   (Saudi Arabia)

^b MAYO CLINIC   (United States)

Author keywords

Cellulitis; Stenotrophomonas

Indexed keywords

AMIKACIN; ANTINEOPLASTIC AGENT; AZTREONAM; CARBAPENEM; CASPOFUNGIN; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; LATAMOXEF; MEROPENEM; METRONIDAZOLE; NETILMICIN; PIPERACILLIN; TIMENTIN; VANCOMYCIN;

ARTICLE; BLOOD CULTURE; CELLULITIS; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ECTHYMA; HUMAN; MYOSITIS; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SKIN BIOPSY; SKIN INFECTION; STENOTROPHOMONAS MALTOPHILIA; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ADULT; AGED; CHILD; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; SKIN DISEASES, BACTERIAL; STENOTROPHOMONAS MALTOPHILIA; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 59849120307     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2008.11.003     Document Type: Article

References (19)

1. Ansari S.R., Hanna H., Hachem R., Jiang Y., Rolston K., and Raad I. Risk factors for infections with multidrug-resistant Stenotrophomonas maltophilia in patients with cancer. Cancer 109 (2007) 2615-2622
2. Apsiarnthanarak A., Mayfield J.L., Garsion T., Malendon M., Dipersio J.F., Victoria J., Fraser, Louis B., and Polish. Risk factors for Stenotrophomonas maltophilia bacteremia in oncology patients: a case control. Infect. Control Hosp. Epidemiol. 24 (2003) 269-274
3. Bottone E.J., Reitano M., Janda J.M., Troy K., and Cuttner J. Pseudomonas maltophilia exoenzyme activity as correlate in pathogenesis of ecthyma gangrenosum. J. Clin. Microbiol. 24 (1989) 995-997
4. Burns R.L., and Lowe L. Xanthomonas maltophilia infection presenting as erythematous nodules. J. Am. Acad. Dermatol. 36 (1997) 836-838
5. Downhour N.P., Petersen E.A., Kruneger T.S., Tangella K.V., and Nix D.E. Severe cellulitis/myositis caused by Stenotrophomonas maltophilia. Ann. Pharmacother. 36 (2002) 63-66
6. Greene S.L., Su W.P., and Muller S.A. Ecthyma gangrenosum: report of clinical, histopathologic, and bacteriologic aspects of eight cases. J. Am. Acad. Dermatol. 11 (1984) 781-787
7. McNamara D.R., Tleyjeh I.M., Berbari E.F., Lahr B.D., Martinez J., Mirzoyev S.A., and Baddour L.M. A predictive model of recurrent lower extremity cellulitis in a population based cohort. Arch. Intern. Med. 167 (2007) 709-715
8. McNamara D.R., Tleyjeh I.M., Berbari E.F., Lahr B.D., Martinez J.W., Mirzoyev S.A., and Baddour L.M. Incidence of lower-extremity cellulitis: a population-based study in Olmsted county, Minnesota. Mayo Clin. Proc. 82 (2007) 817-821
9. Moser C., Jonsson V., Thomsen K., Albrectsen J., Hansen M.M., and Prag J. Subcutaneous lesions and bacteraemia due to Stenotrophomonas maltophilia in three leukaemic patients with neutropenia. Br. J. Dermatol. 136 (1997) 949-952
10. Musher D.M. Cutaneous and soft tissue manifestations of sepsis due to gram negative enteric bacilli. Rev. Infect. Dis. 2 (1980) 855-866
11. Nicodemo A.C., and Garcia Paez J.I. Antimicrobial therapy of Stenotrophomonas maltophilia infections. Eur. J. Clin. Microbiol. Infect. Dis. 26 (2007) 229-237
12. Robert R., Muder, Yu V.L., Dummer J.S., Vinson C., Robert M., and Lumish M. Infections caused by Pseudomonas maltophilia expanding clinical spectrum. Arch. Intern. Med. 147 (1987) 1672-1674
13. Safdar A., and Rolston K.V. Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer. Clin. Infect. Dis. 45 (2007) 1602-1609
14. Sakhnini E., Weissmann A., and Oren I. Fulminant Stenotrophomonas maltophilia soft tissue infection in immunocompromised patients: an outbreak transmitted via tap water. Am. J. Med. Sci. 323 (2002) 269-272
15. Sattler C.A., Mason Jr. E.O., and Kaplan S.L. Nonrespiratory Stenotrophomonas maltophilia infection at a children's hospital. Clin. Infect. Dis. 31 (2000) 1321-1330
16. Smeets J.G.E., Lowe S.H., and Veraat J.C.J.M. Cutaneous infections with Stenotrophomonas maltophilia in patients using immunosuppressive medication. J. Eur. Acad. Dermatol. Vnereol. 21 (2007) 1298-1300
17. Teo W.Y., Chan M.Y., Lam C.M., and Chong C.Y. Skin manifestation of Stenotrophomonas maltophilia-a case report and review article. Ann. Acad. Med. Singapore 35 (2006) 897-900
18. Tleyjeh I.M., and Baddour L.M. Cellulitis. Available at: (2008). http://www.antimicrobe.org/mycinsearch/atvempirictoc.asp Last accessed October, 24
19. Vartivarian S.E., Papadakis K.A., Palacios J.A., Manning J.T., and Anaissie E.J. Mucocutaneous and soft tissue infections caused by Stenotrophomonas maltophilia: a new spectrum. Ann. Intern. Med. 121 (1994) 969-973